Li Y, Jie C, Wang J, Zhang W, Wang J, Deng Y
Medicine (Baltimore). 2024; 103(25):e38596.
PMID: 38905408
PMC: 11191902.
DOI: 10.1097/MD.0000000000038596.
Seth I, Bulloch G, Tan A, Thornell E, Agarwal S
Biomed Hub. 2022; 7(1):1-10.
PMID: 35223872
PMC: 8832185.
DOI: 10.1159/000521053.
Gungel H, Aral H, Erdenen F, Gokce M, Erdur S
Acta Endocrinol (Buchar). 2021; 16(4):417-425.
PMID: 34084232
PMC: 8126384.
DOI: 10.4183/aeb.2020.417.
Mansour S, Browning D, Wong K, Flynn Jr H, Bhavsar A
Clin Ophthalmol. 2020; 14:653-678.
PMID: 32184554
PMC: 7061411.
DOI: 10.2147/OPTH.S236637.
Massa H, Gobej I, Jacquier P, Jonescu-Cuypers C, Le Quoy O
J Int Med Res. 2018; 47(1):188-195.
PMID: 30270801
PMC: 6384471.
DOI: 10.1177/0300060518799004.
ILM peeling in nontractional diabetic macular edema: review and metanalysis.
Rinaldi M, dellOmo R, Morescalchi F, Semeraro F, Gambicorti E, Cacciatore F
Int Ophthalmol. 2017; 38(6):2709-2714.
PMID: 29090356
DOI: 10.1007/s10792-017-0761-6.
The Vitreomacular Interface in Diabetic Retinopathy.
Agarwal D, Gelman R, Prospero Ponce C, Stevenson W, Christoforidis J
J Ophthalmol. 2015; 2015:392983.
PMID: 26425349
PMC: 4573635.
DOI: 10.1155/2015/392983.
Diabetic macular edema: New promising therapies.
Al Shamsi H, Masaud J, Ghazi N
World J Diabetes. 2014; 4(6):324-38.
PMID: 24379924
PMC: 3874493.
DOI: 10.4239/wjd.v4.i6.324.
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.
Messenger W, Beardsley R, Flaxel C
Drug Des Devel Ther. 2013; 7:425-34.
PMID: 23737661
PMC: 3668088.
DOI: 10.2147/DDDT.S44427.
Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.
Saeed A
Clin Ophthalmol. 2013; 7:283-97.
PMID: 23440389
PMC: 3577013.
DOI: 10.2147/OPTH.S37781.
Triple therapy: Phaco-vitrectomy with ILM peeling, retinal endophotocoagulation, and intraoperative use of bevacizumab for diffuse diabetic macular edema.
Robaszkiewicz J, Chmielewska K, Figurska M, Wierzbowska J, Stankiewicz A
Med Sci Monit. 2012; 18(4):CR241-51.
PMID: 22460096
PMC: 3560820.
DOI: 10.12659/msm.882624.
Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.
Hoerauf H, Bruggemann A, Muecke M, Luke J, Muller M, Stefansson E
Graefes Arch Clin Exp Ophthalmol. 2011; 249(7):997-1008.
PMID: 21243370
PMC: 3124640.
DOI: 10.1007/s00417-010-1610-8.
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Haller J, Qin H, Apte R, Beck R, Bressler N, Browning D
Ophthalmology. 2010; 117(6):1087-1093.e3.
PMID: 20299105
PMC: 2911350.
DOI: 10.1016/j.ophtha.2009.10.040.
Morphometry of surgically removed internal limiting membrane during vitrectomy in diabetic macular edema.
Kalvoda J, Duskova J, Kubena A, Povysil C, Kalvodova B
Graefes Arch Clin Exp Ophthalmol. 2009; 247(10):1307-14.
PMID: 19430806
DOI: 10.1007/s00417-009-1100-z.
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Ophthalmology. 2008; 115(9):1447-9, 1449.e1-10.
PMID: 18662829
PMC: 2748264.
DOI: 10.1016/j.ophtha.2008.06.015.
Perifoveal vitreous detachment and its macular complications.
Johnson M
Trans Am Ophthalmol Soc. 2006; 103:537-67.
PMID: 17057817
PMC: 1447588.
Vitrectomy seems to be beneficial for advanced diffuse diabetic macular oedema not responding to laser treatment.
Lovestam-Adrian M, Larsson J
Int Ophthalmol. 2006; 26(1-2):21-6.
PMID: 16779572
DOI: 10.1007/s10792-005-4834-6.
Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.
Shah S, Patel M, Thomas D, Aldington S, Laidlaw D
Br J Ophthalmol. 2005; 90(1):33-6.
PMID: 16361663
PMC: 1856901.
DOI: 10.1136/bjo.2005.072934.
Assessment of macular function by multifocal electroretinogram in diabetic macular edema before and after vitrectomy.
Ma J, Yao K, Jiang J, Wu D, Gao R, Yin J
Doc Ophthalmol. 2005; 109(2):131-7.
PMID: 15881258
DOI: 10.1007/s10633-004-2890-2.
A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.
Thomas D, Bunce C, Moorman C, Laidlaw D
Br J Ophthalmol. 2004; 89(1):81-6.
PMID: 15615752
PMC: 1772459.
DOI: 10.1136/bjo.2004.044966.